1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

New Horizons Clinical Research

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

1988

Location

Cincinnati OH US

Primary Industry

Pharmaceuticals

About

Based in Ohio, US, and founded in 1988, New Horizons Clinical Research operates as a multi-therapeutic clinical research organization. The company was founded by Dr. Gregory Gottschlich. In 2017, New Horizons Clinical Research was recapitalized by NaviMed Capital and merged into Velocity Clinical Research, Inc. The company provides clinical research on hyperlipidemia, diabetes, osteoarthritis, gout, chronic pain, allergy, asthma, chronic obstructive pulmonary disease (COPD), hypertension, and coronary artery disease (CAD).
Current Investors
Velocity Clinical Research Inc.

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Deals

Deals Type
Secondary Buyout
Add-on
Merger
Recapitalisation
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Velocity Clinical Research Inc. 08 Apr 2021
Completed New Horizons Clinical Research 07 Feb 2019
Completed New Horizons Clinical Research 01 Dec 2017
Completed New Horizons Clinical Research 01 Dec 2017
Displaying 1-4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.